Global Implantable Drug Eluting Devices Market is set to experience significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around USD 12.8 Billion as of 2022. As per Future Market Insights projections, contraceptive drug eluting devices products hold a substantial share of over 39.8% in 2021 within the global market.
Data Points | Market Insights |
---|---|
Market Value 2021 | USD 12.1 Billion |
Market Value 2022 | USD 12.8 Billion |
Market Value 2029 | USD 19.3 Billion |
CAGR 2022 to 2029 | 6.0% |
Market Share of Top 5 Countries | 76.5% |
With the growth in demand for minimally-invasive procedures, implantable drug eluting devices are accumulating a rising range in terms of market penetration, which are established by key market leaders.
Similarly, start-up companies as well as majorly rooted corporations over the globe are working hard to develop novel implantable drug delivery technologies, using a wide range of knowledge available in the network which includes research institutions, universities, teaching hospitals, and companies.
Due to a massive demand for combination products such as drug eluting devices, major players in the market are adopting competitive strategies such as acquisitions, mergers, as well as collaborations for the development and augmentation of products in the market.
Particulars | Details |
---|---|
H1, 2021 | 6.03% |
H1, 2022 Projected | 6.00% |
H1, 2022 Outlook | 5.90% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 | (-) 13 ↓ |
According to Future Market Insights’ analysis, the global implantable drug eluting devices market will observe a diminished change in the Basis Point Share (BPS) by nearly 13 BPS in H1- 2022 (O) as compared with H1-2021. The attribute of non-biodegradable implants, which includes the requirement for surgical removal or the accumulation of polymer in the body after usage, has a negative impact on the total market.
Non-biodegradable implants are generally more traumatic to remove than they are to place. This is based on available clinical studies data. The comparative analysis and market growth rate of the global implantable drug eluting devices market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS. Furthermore, the manufacture of implants necessitates the use of huge amounts of organic solvent, which might affect drug stability and toxicity, as well as raise environmental problems.
On the contrary, numerous factors present several benefits to the overall implantable drug eluting devices market, including the adoption of compression as a manufacturing technique for implantable drugs, which refrains from the use of heat or solvents, making it a suitable method for the manufacture of implants containing heat or solvent sensitive compounds such proteins or peptides.
This is set to advance the manufacturing capacities of key producers within the global industry space.
The market value for Implantable Drug Eluting Devices holds nearly 5.8% of the overall USD 208.0 Billion Drug Delivery Devices market in 2021.
Implantable drug eluting devices provide numerous distinctive advantages which include the exceptional prospects of site-specificity, localization, and targeted drug delivery process.
The applications of implantable drug eluting devices are indispensable when considered under the scope of cardiology, ophthalmology, birth control, opioid addiction, pain management, diabetes management, contraception, as well as cancer therapy. The targeted drug delivery systems improve the efficacy of treatment (oncology and cardiology) and assist with the reduction of side effects by preventing damage to healthy tissue.
The implantable drug eluting devices are segmented into two main types: active drug eluting devices and passive drug eluting devices.
The technologies essentially incorporated in the active drug eluting devices are electromechanical and osmotic pressure gradients. Furthermore, the passive drug eluting devices are sub-segmented into 2 types which include biodegradable implants and non-biodegradable implants, wherein, the biodegradable implants are polyester amide and Polylactic glycolic acids devised and the non-biodegradable implantable devices are made using silicon, polyethylene-vinyl acetate, and thermoplastic polyurethane.
The non-biodegradable implants possess wide-ranging applications in diabetes, contraception, hormone regulation, pain management, cancer treatment, etc. Implantable drug delivery devices commonly comprise a drug reservoir enclosed by a polymer or a mixture of a drug-polymer.
The implant, when incorporated into the desired, localized area of the body, releases the drug at a pre-calculated rate whilst the polymer degrades.
The effective drug delivery system through implantable drug eluting devices is thus set to gain traction in terms of adoption over the forecast period, owing to the specificity of the target site and the rate of drug dissolution into the localized area of therapy.
The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 6.0%.
The implantable drug eluting devices is predicted to exhibit lucrative growth over the forecast period. This growth can be associated with the rising adoption of patient-controlled devices and increasing the incidence of peripheral and coronary artery diseases. Additionally, the key market players are displaying extensive focus on clinical trials of bio-reabsorbable stents and implantable drug infusion pumps.
Therefore, the growing adoption by patients and physicians, and rising demand for minimally invasive surgeries are set to offer growth opportunities to key market players in the development of novel implantable drug-eluting devices. Furthermore, the rising incidence of cardiovascular and chronic diseases over the globe is generating growth opportunities for the global implantable drug eluting devices market.
According to the WHO, cardiovascular diseases are one of the major causes of mortality globally.
Several research and clinical studies are currently taking place for the improvement of the functioning of existing drug eluting stents and devices. Research in this area is thus focused on the evaluation and development of novel and augmented drug eluting devices, which uphold notable clinical benefits and eliminate safety concerns regarding their long-term application. The innovative efforts in research on next-generation drug eluting devices are expected to further progress procedures such as endothelialization and rapid arterial healing.
These factors are thus comprehensively set to promote the growth of the implantable drug eluting devices market throughout the forecast period.
The factors associated with risks associated with the limited demand and value growth of the implantable drug eluting devices include the process of product recalls, which are indispensable for public health and safety as it leads to the voluntary action of manufacturers and distributors to carry out their responsibility that presents a risk of injury or defective or gross deception of products.
Additionally, pending approvals of products by regulatory bodies may hinder the growth of injunctions which can restrain the sale of products and may remarkably divert the attention of the management and technical personnel in the market. In the event of approval pending, the company's financial condition, business, and results of operations could be adversely affected. Moreover, several implantable drug eluting devices pose a problem in terms of patient adherence, terms of discomfort upon the implants being incorporated into them.
The ongoing biodegradation of the drug-eluting stents sometimes makes it difficult to maintain the accurate dose at the end of its lifetime. There is always a risk of device failure, which may result in another surgical involvement to correct the device.
Another factor of concern includes the fact that most implants possess an inadequate loading capacity owing to their small size. This gives way to some specific potent medicines for appropriate delivery by implantable devices.
The concerns arising from bodily reaction to a foreign substance also conceive a restrictive growth in the deployment of implants in lieu of its biocompatibility and safety. These factors collectively induce restraint in the growth of the implantable drug eluting devices market, however, augmented and personalized implant designing may prove to enhance the efficacy of the implanted drug delivery process.
The USA dominates the North American region with a total market share of over 94.1% in 2021 and is projected to continue experiencing high growth throughout the forecast period.
The vast majority of shares gained by the USA in the implantable drug eluting devices market are owed to the factors associated with rising disease burden, increasing geriatric population, and the developing healthcare infrastructure which offers reimbursement opportunities for new procedures.
Germany is set to exhibit a CAGR of over 6.2% in the European implantable drug eluting devices market during the forecast period. The lucrative growth in the region is associated with the emergence of key and established players in the country, focusing on research and innovative methodologies for drug delivery and targeted site delivery systems.
China holds a 46.1% market revenue share in the East Asia market in 2021 and is projected to increase at a CAGR rate of 8.7% during the forecast period. The growth of the implantable drug eluting devices market in the country is attributed to the development of novel drug delivery technologies, such as an implantable nanogenerator, which can be adopted for precise drug delivery systems. Furthermore, increasing government funding for research and development activities is set to augment the China implantable drug eluting devices market over the forecast period.
In 2021, Japan held a 39.3% share in the East Asia implantable drug eluting devices market and is projected to expand at a CAGR of 8.2% from 2022 to 2029. The growth is associated with the rapid adoption of automated systems in the country, including models for site-specific and targeted drug delivery systems. These augmentations are cost-effective and reduce the error rate during clinical trials.
Contraceptive drug eluting devices project lucrative growth at a CAGR of 6.0% till the end of the forecast period, with a market share of around 39.8% in 2021. The growth is associated with the factor of increasing awareness in terms of female and reproductive health over the globe, and the efforts to minimize the mortality and morbidity rate associated with female reproductive health.
Passive drug eluting device technology holds a revenue share of 96.2% in 2021 and is projected to hold a share over the forecast period with the estimation being 96.6%. The segment holds the maximum revenue share due to the wide-ranging applications of passive drug eluting devices in the field of oncology, cardiology, pain management, contraception, etc.
Cardiovascular applications hold a revenue share of 45.1% in 2021 and are projected to hold a share over the forecast period with the estimation being 47.3%. The segment gains traction with the rising incidence of chronic diseases and the risks associated with infectious agents among the geriatric population.
Intravascular implantation type holds a revenue share of 44.1% in 2021 and is projected to hold a share over the forecast period with the estimation being 46.1%. The extensive ranging applications of the intravascular implants as well as the efficient patient adherence and outcomes have contributed to this method being implemented widely across several treatment indications.
Hospitals hold a revenue share of 61.9% in 2021 and are projected to hold a share over the forecast period with the estimation being 66.0%. The process of targeted drug delivery through implantable drug eluting devices requires the aid of skilled physicians with patient data for close monitoring in the event of implant rejection or other adverse events. Thus, the hospital segment accounts for a massive share of the implantable drug eluting devices market.
Corporate tie-ups amongst implantable drug eluting device manufacturers, acquisitions, expansion, product launches, agreements, and increasing clinical trials and research activities are the key strategies adopted by manufacturers to increase product sales in different geographies.
Similarly, recent developments related to companies operating in the implantable drug eluting devices market have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2029 |
Historical Data Available for | 2014 to 2021 |
Market Analysis | USD Million for Value |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, Turkey |
Key Market Segments Covered | Product, Technology, Application, Implantation Type, End User, and Region |
Key Companies Profiled | Pfizer Inc.; Medtronic Inc.; Merck & Co., In; Bayer AG; JOHNSON & JOHNSON; SurModics Inc.; AstraZeneca Plc.; Boston Scientific Corporation; Titan Pharmaceuticals, Inc.; BIOTRONIK, INC.; Abbott Laboratories; Allergan, Inc.; Bausch and Lomb, Inc.; Alimera Sciences; REVA Medical, Inc. |
Pricing | Available upon Request |
Table 01: Global Market Volume (in Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
Table 02: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
Table 03: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 04: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 05: Global Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 06: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 07: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 08: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 09: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 10: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 11: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 12: North America Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 13: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 14: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 15: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 16: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 17: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 18: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 19: Latin America Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 20: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 21: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 22: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 23: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 24: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 25: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 26: Europe Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 27: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 28: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 29: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 30: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 31: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 32: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 33: East Asia Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 34: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 35: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 36: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 37: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 38: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 39: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 40: South Asia Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 41: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 42: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 43: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 44: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 45: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 46: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 47: Oceania Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 48: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 49: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 50: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 51: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 52: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 53: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 54: Middle East and Africa Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 55: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 56: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 57: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 58: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 59: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 60: China Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 61: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 62: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 63: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 64: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 65: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 66: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 67: India Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 68: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 69: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 70: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Table 71: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Table 72: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 73: India Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Table 74: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Table 75: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Table 76: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 01: Global Market Value Share, by Product (2022E)
Figure 02: Global Market Value Share, by Technology (2022E)
Figure 03: Global Market Value Share, by Implantation Type (2022E)
Figure 04: Global Market Value Share, by Application (2022E)
Figure 05: Global Market Value Share, by End User (2022E)
Figure 06: Global Market Value Share, by Region (2022E)
Figure 07: Global Market Size (US$ Million) Analysis, 2014 to 2021
Figure 08: Global Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2029
Figure 09: Global Market Absolute $ Opportunity Analysis, 2022 to 2029
Figure 10: Global Market Volume (in Units) Analysis, 2014 to 2021
Figure 11: Global Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2022 to 2029
Figure 12: Global Market Analysis by Region –2022 & 2029
Figure 13: Global Market Y-o-Y Growth Projections by Region, 2022 to 2029
Figure 14: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
Figure 15: Global Market Analysis by Technology –2022 & 2029
Figure 16: Global Market Y-o-Y Growth Projections by Technology, 2022 to 2029
Figure 17: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 18: Global Market Analysis by Product –2022 & 2029
Figure 19: Global Market Y-o-Y Growth Projections by Product, 2022 to 2029
Figure 20: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 21: Global Market Analysis by Application –2022 & 2029
Figure 22: Global Market Y-o-Y Growth Projections by Application, 2022 to 2029
Figure 23: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 24: Global Market Analysis by Implantation Type –2022 & 2029
Figure 25: Global Market Y-o-Y Growth Projections by Implantation Type, 2022 to 2029
Figure 26: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 27: Global Market Analysis by End User –2022 & 2029
Figure 28: Global Market Y-o-Y Growth Projections by End User, 2022 to 2029
Figure 29: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 30:North America Market Size (US$ Million) Analysis, 2014 to 2021
Figure 31: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 32: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 33: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 34: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 35: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 36: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 37: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 38:Latin America Market Size (US$ Million) Analysis, 2014 to 2021
Figure 39: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 40: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 41: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 42: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 43: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 44: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 45: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 46:Europe Market Size (US$ Million) Analysis, 2014 to 2021
Figure 47: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 48: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 49: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 50: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 51: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 52: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 53: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 54:East Asia Market Size (US$ Million) Analysis, 2014 to 2021
Figure 55: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 56: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 57: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 58: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 59: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 60: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 61: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 62:South Asia Market Size (US$ Million) Analysis, 2014 to 2021
Figure 63: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 64: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 65: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 66: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 67: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 68: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 69: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 70:Oceania Market Size (US$ Million) Analysis, 2014 to 2021
Figure 71: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 72: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 73: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 74: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 75: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 76: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 77: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 78:Middle East and Africa Market Size (US$ Million) Analysis, 2014 to 2021
Figure 79: Middle East and Africa Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 80: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Figure 81: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 82: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 83: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 84: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 85: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 86:China Market Size (US$ Million) Analysis, 2014 to 2021
Figure 87: China Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 88: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 89: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 90: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 91: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 92: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 93:India Market Size (US$ Million) Analysis, 2014 to 2021
Figure 94: India Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 95: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 96: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 97: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 98: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 99: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
Figure 100:Brazil Market Size (US$ Million) Analysis, 2014 to 2021
Figure 101: Brazil Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 102: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
Figure 103: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type
Figure 104: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
Figure 105: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
Figure 106: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology
The global implantable drug eluting devices market is worth USD 12.1 Billion at present and is set to expand 1.5 X over the next seven years.
The implantable drug eluting devices market is expected to reach USD 19.3 Billion by the end of 2029, with sales revenue expected to register 6.0% CAGR.
Growing research collaborations and distribution of implantable drug eluting devices by key market leaders, new product launches and government initiatives are some of the key trends being witnessed in this marketplace.
The USA, Germany, the United Kingdom, France, and China are expected to drive demand in the implantable drug eluting devices market.
North America is one of the key markets for implantable drug eluting devices, with the USA expected to account for over 95.3% of the North American market during the forecast period.
Demand for implantable drug eluting devices in Europe is expected to register a growth of 4.9% over the next seven years.
The USA, United Kingdom, and Germany are key producers of implantable drug eluting device products.
Pfizer Inc., Medtronic Inc., Merck & Co. In, Bayer AG, JOHNSON & JOHNSON, SurModics Inc., AstraZeneca Plc., Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, INC., Abbott Laboratories, Allergan, Inc., Bausch and Lomb, Inc., Alimera Sciences, and REVA Medical, Inc. are the key exporters of implantable drug eluting devices market.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.